Samson Rock Capital’s AstraZeneca AZN Stock Holding History

Samson Rock Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-105,640	Closed	-$10.6M	–	53
2020 Q4	$10.6M	Buy	+105,640	New	+$11.2M	6.21%	4

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Samson Rock Capital's AZN Position: Q1 2021 in Review

Samson Rock Capital sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 105,640 shares — an estimated $10.6M sold.

Samson Rock Capital first reported a position in AZN in Q4 2020 and held it in 1 quarter. The position peaked at $10.6M in Q4 2020. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

Samson Rock Capital reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
Samson Rock Capital sold 105,640 AstraZeneca shares in Q1 2021, an estimated $10.6M.
Samson Rock Capital first reported a position in AstraZeneca in Q4 2020 and held it in 1 quarter.
Samson Rock Capital's AstraZeneca position peaked at $10.6M in Q4 2020.
756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Samson Rock Capital's 13F filing for Q1 2021, filed 5 May 2021.